These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 18434589

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.
    Conway JG, McDonald B, Parham J, Keith B, Rusnak DW, Shaw E, Jansen M, Lin P, Payne A, Crosby RM, Johnson JH, Frick L, Lin MH, Depee S, Tadepalli S, Votta B, James I, Fuller K, Chambers TJ, Kull FC, Chamberlain SD, Hutchins JT.
    Proc Natl Acad Sci U S A; 2005 Nov 01; 102(44):16078-83. PubMed ID: 16249345
    [Abstract] [Full Text] [Related]

  • 3. The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model.
    Ohno H, Uemura Y, Murooka H, Takanashi H, Tokieda T, Ohzeki Y, Kubo K, Serizawa I.
    Eur J Immunol; 2008 Jan 01; 38(1):283-91. PubMed ID: 18085662
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.
    Paniagua RT, Chang A, Mariano MM, Stein EA, Wang Q, Lindstrom TM, Sharpe O, Roscow C, Ho PP, Lee DM, Robinson WH.
    Arthritis Res Ther; 2010 Jan 01; 12(1):R32. PubMed ID: 20181277
    [Abstract] [Full Text] [Related]

  • 6. RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents.
    Xu D, Kim Y, Postelnek J, Vu MD, Hu DQ, Liao C, Bradshaw M, Hsu J, Zhang J, Pashine A, Srinivasan D, Woods J, Levin A, O'Mahony A, Owens TD, Lou Y, Hill RJ, Narula S, DeMartino J, Fine JS.
    J Pharmacol Exp Ther; 2012 Apr 01; 341(1):90-103. PubMed ID: 22228807
    [Abstract] [Full Text] [Related]

  • 7. FR177995, a novel vacuolar ATPase inhibitor, exerts not only an inhibitory effect on bone destruction but also anti-immunoinflammatory effects in adjuvant-induced arthritic rats.
    Niikura K, Nakajima S, Takano M, Yamazaki H.
    Bone; 2007 Apr 01; 40(4):888-94. PubMed ID: 17157574
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. S-Adenosyl-L-homocysteine hydrolase inhibitor mediates immunosuppressive effects in vivo: suppression of delayed type hypersensitivity ear swelling and peptidoglycan polysaccharide-induced arthritis.
    Saso Y, Conner EM, Teegarden BR, Yuan CS.
    J Pharmacol Exp Ther; 2001 Jan 01; 296(1):106-12. PubMed ID: 11123369
    [Abstract] [Full Text] [Related]

  • 13. Pyrido[2,3-d]pyrimidin-5-ones: a novel class of antiinflammatory macrophage colony-stimulating factor-1 receptor inhibitors.
    Huang H, Hutta DA, Rinker JM, Hu H, Parsons WH, Schubert C, DesJarlais RL, Crysler CS, Chaikin MA, Donatelli RR, Chen Y, Cheng D, Zhou Z, Yurkow E, Manthey CL, Player MR.
    J Med Chem; 2009 Feb 26; 52(4):1081-99. PubMed ID: 19193011
    [Abstract] [Full Text] [Related]

  • 14. 5-(4-((4-[(18)F]Fluorobenzyl)oxy)-3-methoxybenzyl)pyrimidine-2,4-diamine: a selective dual inhibitor for potential PET imaging of Trk/CSF-1R.
    Bernard-Gauthier V, Schirrmacher R.
    Bioorg Med Chem Lett; 2014 Oct 15; 24(20):4784-90. PubMed ID: 25257201
    [Abstract] [Full Text] [Related]

  • 15. Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.
    Hope HR, Anderson GD, Burnette BL, Compton RP, Devraj RV, Hirsch JL, Keith RH, Li X, Mbalaviele G, Messing DM, Saabye MJ, Schindler JF, Selness SR, Stillwell LI, Webb EG, Zhang J, Monahan JB.
    J Pharmacol Exp Ther; 2009 Dec 15; 331(3):882-95. PubMed ID: 19720877
    [Abstract] [Full Text] [Related]

  • 16. Bone protective effect of simvastatin in experimental arthritis.
    Funk JL, Chen J, Downey KJ, Clark RA.
    J Rheumatol; 2008 Jun 15; 35(6):1083-91. PubMed ID: 18464303
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor alpha-independent mouse model.
    Plater-Zyberk C, Joosten LA, Helsen MM, Koenders MI, Baeuerle PA, van den Berg WB.
    Ann Rheum Dis; 2009 May 15; 68(5):721-8. PubMed ID: 18495731
    [Abstract] [Full Text] [Related]

  • 20. Dual effect of nitric oxide donor on adjuvant arthritis.
    Gomaa AA, Elshenawy MM, Afifi NA, Mohammed EA, Thabit RH.
    Int Immunopharmacol; 2009 Apr 15; 9(4):439-47. PubMed ID: 19193354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.